SynthesisPloS one2013

Angiogenesis inhibitor bevacizumab increases the risk of ischemic heart disease associated with chemotherapy: a meta-analysis.

Xing-Lin Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.